Bradykinin promotes the Chemotactic invasion of primary brain tumors

Journal of Neuroscience

Volumn 31, Issue 13, 2011, Pages 4858-4867

  Montana, Vedrana ^a   Sontheimer, Harald ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ; BRADYKININ B2 RECEPTOR; SHORT HAIRPIN RNA;

ANIMAL TISSUE; ARTICLE; BRAIN BLOOD VESSEL; CALCIUM SIGNALING; CANCER INVASION; CELL COUNT; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; FEMALE; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; BRADYKININ; BRAIN NEOPLASMS; CELL LINE, TUMOR; CHEMOTAXIS; FEMALE; GENE KNOCKDOWN TECHNIQUES; GLIOMA; HUMANS; MALE; NEOPLASM INVASIVENESS; NEUROGLIA; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, BRADYKININ B2; SIGNAL TRANSDUCTION;

EID: 79955711577     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.3825-10.2011     Document Type: Article

References (43)

1. Bordey A, Sontheimer H, Trouslard J (2000) Muscarinic activation of BK channels induces membrane oscillations in glioma cells and leads to inhibition of cell migration. J Membr Biol 176:31-40.
2. Bork K, Yaosothan U, Kirckpatrick P (2008) Icatibant. Nat Rev Drug Discovery 7:801-802.
3. Coller KE, Berger KL, Heaton NS, Cooper JD, Yoon R, Randall G (2009) RNA interference and single particle tracking analysis of hepatitis C virus endocytosis. PLoS Pathog 5:e1000702.
4. Savard M, Bovenzi V, Dubuc C, Tremblay L, Tsanaclis AM, Fortin D, Lepage M, Gobeil F Jr (2010) Selective tumor blood-brain barrier opening with the kinin B2 receptor agonist [Phe(8)psi(CH(2)NH)Arg(9)]-BK in a F98 glioma rat model: an MRI study. Neuropeptides 44:177-185.
5. Deshane J, Garner CC, Sontheimer H (2003) Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2. J Biol Chem 278:4135-4144.
6. Ewert S, Johansson B, Holm M, Helander HF, Fandriks L (2003) The bradykinin BK2 receptor mediates angiotensin II receptor type 2 stimulated rat duodenal mucosal alkaline secretion. BMC Physiol 3:1.
7. Fabian A, Fortmann T, Bulk E, Bomben VC, Sontheimer H, Schwab A (2011) Chemotaxis of MDCK-F cells toward fibroblast growth factor-2 depends on transient receptor potential canonical channel. Pflugers Arch 461:295-306.
8. Friedberg MH, Glantz MJ, Klempner MS, Cole BF, Perides G (1998) Specific matrix metalloproteinase profiles in the cerebrospinal fluid correlated with the presence of malignant astrocytomas, brain metastases, and carcinomatous meningitis. Cancer 82:923-930.
9. Giannone G, Rondé P, Gaire M, Haiech J, Takeda K (2002) Calcium oscillations trigger focal adhesion disassembly in human U87 astrocytoma cells. J Biol Chem 277:26364-26371.
10. Habela CW, Ernest NJ, Swindall AF, Sontheimer H (2009) Chloride accumulation drives volume dynamics underlying cell proliferation and migration. J Neurophysiol 101:750-757.
11. Higashida H, Yokoyama S, Hoshi N, Hashii M, Egorova A, Zhong ZG, Noda M, Shahidullah M, Taketo M, Knijnik R, Kimura Y, Takahashi H, Chen XL, Shin Y, Zhang JS (2001) Signal transduction from bradykinin, angiotensin, adrenergic and muscarinic receptors to effector enzymes, including ADP-ribosyl cyclase. Biol Chem 382:23-30.
12. Hsieh HL, Wu CY, Yang CM (2008) Bradykinin induces matrix metalloproteinase- 9 expression and cell migration through a PKC-deltadependent ERK/Elk-1 pathway in astrocytes. Glia 56:619-632.
13. Ifuku M, Färber K, Okuno Y, Yamakawa Y, Miyamoto T, Nolte C, Merrino VF, Kita S, Iwamoto T, Komuro I, Wang B, Cheung G, Ishikawa E, Ooboshi H, Bader M, Wada K, Kettenmann H, Noda M (2007) Bradykinin-induced microglial migration mediated by B1-bradykinin receptors depends on Ca2+ influx via reverse-mode activity of the Na+/Ca2+ exchanger. J Neurosci 27:13065-13073.
14. Ishiuchi S, Tsuzuki K, Yoshida Y, Yamada N, Hagimura N, Okado H, Miwa A, Kurihara H, Nakazato Y, Tamura M, Sasaki T, Ozawa S (2002) Blockage of Ca(2+)-permeableAMPAreceptors suppresses migration and induces apoptosis in human glioblastoma cells. Nat Med 8:971-978.
15. Jacobelli J, Bennett FC, Pandurangi P, Tooley AJ, Krummel MF (2009) MF Myosin-IIA and ICAM-1 regulate the interchange between two distinct modes of T cell migration. J Immunol 182:2041-2050.
16. Joseph K, Kaplan AP (2005) Formation of bradykinin: a major contributor to the innate inflammatory response. Adv Immunol 86:159-208.
17. Kaba SE, Kyritsis AP (1997) Recognition and management of gliomas. Drugs 53:235-244.
18. Komuro H, Rakic P (1996) Intracellular Ca2+ fluctuations modulate the rate of neuronal migration. Neuron 17:275-285.
19. Kronlage M, Song J, Sorokin L, Isfort K, Schwerdtle T, Leipziger J, Robaye B, Conley PB, Kim HC, Sargin S, Schön P, Schwab A, Hanley PJ (2010) Autocrine purinergic receptor signaling is essential for macrophage chemotaxis. Sci Signal 3:ra55.
20. Laerum OD, Bjerkvig R, Steinsvåg SK, de Ridder L (1984) Invasiveness of primary brain tumors. Cancer Metastasis Rev 3:223-236.
21. Lu DY, Leung YM, Huang SM, Wong KL (2010) Bradykinin-induced cell migration and COX-2 production mediated by the bradykinin B1 receptor in glioma cells. J Cell Biochem 110:141-150.
22. Lyons SA, Chung WJ, Weaver AK, Ogunrinu T, Sontheimer H (2007) Autocrine glutamate signaling promotes glioma cell invasion. Cancer Res 67:9463-9471.
23. Martineau M, Galli T, Baux G, Mothet JP (2008) Confocal imaging and tracking of the exocytotic routes for D-serine-mediated gliotransmission. Glia 56:1271-1284.
24. Martins AH, Alves JM, Trujillo CA, Schwindt TT, Barnabé GF, Motta FL, Guimaraes AO, Casarini DE, Mello LE, Pesquero JB, Ulrich H (2008) Kinin-B2 receptor expression and activity during differentiation of embryonic rat neurospheres. Cytometry A 73:361-368.
25. Montana V, Ni Y, Sunjara V, Hua X, Parpura V (2004) Vesicular glutamate transporter-dependent glutamate release from astrocytes. J Neurosci 24:2633-2642.
26. Moreau ME, Garbacki N, Molinaro G, Brown NJ, Marceau F, Adam A (2005) The kallikrein-kinin system: current and future pharmacological targets. J Pharmacol Sci 99:6-38.
27. Parpura V, Basarsky TA, Liu F, Jeftinija K, Jeftinija S, Haydon PG (1994) Glutamate-mediated astrocyte-neuron signalling. Nature 369:744-747.
28. Raidoo DM, Sawant S, Mahabeer R, Bhoola KD (1999) Kinin receptors are expressed in human astrocytic tumour cells. Immunopharmacology 43:255-263.
29. Rao JS (2003) Molecular mechanisms of glioma invasiveness: the role of proteases. Nat Rev Cancer 3:489-501.
30. Ratajczak MZ, Zuba-Surma E, Kucia M, Reca R, Wojakowski W, Ratajczak J (2006) The pleiotropic effects of the SDF-1-CXCR4 axis in organogenesis, regeneration and tumorigenesis. Leukemia 20:1915-1924.
31. Reetz G, Reiser G (1996) [Ca 2+]i oscillations induced by bradykinin in rat glioma cells associated with Ca2+ store-dependent Ca2+ influx are controlled by cell volume and by membrane potential. Cell Calcium 19:143-156.
32. Rondé P, Giannone G, Gerasymova I, Stoeckel H, Takeda K, Haiech J (2000) Mechanism of calcium oscillations in migrating human astrocytoma cells. Biochim Biophys Acta 1498:273-280.
33. Sarin H, Kanevsky AS, Fung SH, Butman JA, Cox RW, Glen D, Reynolds R, Auh S (2009) Metabolically stable bradykinin B2 receptor agonists enhance transvascular drug delivery into malignant brain tumors by increasing drug half-life. J Transl Med 7:33.
34. Uchida M, Chen Z, Liu Y, Black KL (2002) Overexpression of bradykinin type 2 receptors on glioma cells enhances bradykinin-mediated bloodbrain tumor barrier permeability increase. Neurol Res 24:739-746.
35. Verderio C, Matteoli M (2001) ATP mediates calcium signaling between astrocytes and microglial cells: modulation by IFN-gamma. J Immunol 166:6383-6391.
36. Wang YB, Liu YH (2009) Bradykinin selectively modulates the bloodtumor barrier via calcium-induced calcium release. J Neurosci Res 87:660-667.
37. Wang YB, Peng C, Liu YH (2007) Low dose of bradykinin selectively increases intracellular calcium in glioma cells. J Neurol Sci 258:44-51.
38. Weaver AK, Bomben VC, Sontheimer H (2006) Expression and function of calcium-activated potassium channels in human glioma cells. Glia 54:223-233.
39. Xia CY, Zhang Z, Xue YX, Wang P, Liu YH (2009) Mechanisms of the increase in the permeability of the blood-tumor barrier obtained by combining low-frequency ultrasound irradiation with small-dose bradykinin. J Neurooncol 94:41-50.
40. Yang WH, Chang JT, Hsu SF, Li TM, Cho DY, Huang CY, Fong YC, Tang CH (2010) Bradykinin enhances cell migration in human chondrosarcoma cells through BK receptor signaling pathways. J Cell Biochem 109:82-92.
41. Zagzag D, Esencay M, Mendez O, Yee H, Smirnova I, Huang Y, Chiriboga L, Lukyanov E, Liu M, Newcomb EW (2008) Hypoxia- and vascular endothelial growth factor-induced stromal cell-derived factor-1alpha/CXCR4 expression in glioblastomas: one plausible explanation of Scherer's structures. Am J Pathol 173:545-560.
42. Zhang Z, Xia C, Xue Y, Liu Y (2009) Synergistic effect of low-frequency ultrasound and low-dose bradykinin on increasing permeability of the blood-tumor barrier by opening tight junction. J Neurosci Res 87:2282-2289.
43. Zhao Y, Xue Y, Liu Y, Fu W, Jiang N, An P, Wang P, Yang Z, Wang Y (2005) Study of correlation between expression of bradykinin B2 receptor and pathological grade in human gliomas. Br J Neurosurg 19:322-326.